Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FP81M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $101,164
Award facts
- Contract value 100% obligated
- $101,164.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $101,164.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and completion by September 24, 2025. This non-set-aside award was competitively procured and represents a direct delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (contract SPE2DX valued at $999,999,999.00 through December 2026). Repatha is a PCSK9 inhibitor used to treat high cholesterol in patients with cardiovascular disease, supporting the Department of Defense's medical supply requirements for active-duty personnel, veterans, and other eligible beneficiaries.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its primary contract with DLA Troop Support Medical. This prime IDC provides comprehensive pharmaceutical support globally and enables the company to supply brand-name medications, generic drugs, vaccines, and specialized medical devices across multiple therapeutic areas to support military healthcare programs. The current delivery order for Repatha reflects the company's continued role as a key supplier of specialty pharmaceuticals within the Defense Health Agency's pharmaceutical prime vendor network.
Quick answers
Who was awarded contract SPE2DB25FP81M?
SPE2DB25FP81M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FP81M worth?
The government has obligated $101,164 on SPE2DB25FP81M.
Is contract SPE2DB25FP81M an order under another contract?
Yes. SPE2DB25FP81M is a delivery order under SPE2DB20D1109, an indefinite delivery contract.
Was contract SPE2DB25FP81M competed?
The extent of competition for SPE2DB25FP81M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award